When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
APLS - Should Amgen Finally Buy Alexion Pharmaceuticals?
Apellis Pharmaceuticals Inc.
Biotech investors have been predicting Amgen's (NASDAQ: AMGN) potential purchase of Alexion Pharmaceuticals(NASDAQ: ALXN) for over a year, and the rumor has picked up steam following signals that the big biotech is ready to make some deals.
At a rumored offering price of $200 per share, Amgen would end up paying $45 billion for the rare-disease drugmaker. A handful of analysts think the acquisition's a terrific idea, but they also work for investment banks that stand to earn a lot of money facilitating such a big transaction.